| Year |
Citation |
Score |
| 2023 |
Mehdawi LM, Ghatak S, Chakraborty P, Sjölander A, Andersson T. LGR5 Expression Predicting Poor Prognosis Is Negatively Correlated with WNT5A in Colon Cancer. Cells. 12. PMID 37998393 DOI: 10.3390/cells12222658 |
0.353 |
|
| 2022 |
Yadav V, Jobe N, Satapathy SR, Mohapatra P, Andersson T. Increased MARCKS Activity in BRAF Inhibitor-Resistant Melanoma Cells Is Essential for Their Enhanced Metastatic Behavior Independent of Elevated WNT5A and IL-6 Signaling. Cancers. 14. PMID 36551563 DOI: 10.3390/cancers14246077 |
0.322 |
|
| 2021 |
Jobe NP, Åsberg L, Andersson T. Reduced WNT5A signaling in melanoma cells favors an amoeboid mode of invasion. Molecular Oncology. PMID 33969605 DOI: 10.1002/1878-0261.12974 |
0.359 |
|
| 2020 |
Mohapatra P, Yadav V, Toftdahl M, Andersson T. WNT5A-Induced Activation of the Protein Kinase C Substrate MARCKS Is Required for Melanoma Cell Invasion. Cancers. 12. PMID 32033033 DOI: 10.3390/Cancers12020346 |
0.418 |
|
| 2019 |
Osman J, Bellamkonda K, Liu Q, Andersson T, Sjölander A. The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer. Anticancer Research. 39: 1719-1728. PMID 30952711 DOI: 10.21873/Anticanres.13278 |
0.407 |
|
| 2018 |
Mohapatra P, Prasad CP, Andersson T. Combination therapy targeting the elevated interleukin-6 level reduces invasive migration of BRAF inhibitor-resistant melanoma cells. Molecular Oncology. PMID 30582770 DOI: 10.1002/1878-0261.12433 |
0.684 |
|
| 2018 |
Prasad CP, Manchanda M, Mohapatra P, Andersson T. WNT5A as a therapeutic target in breast cancer. Cancer Metastasis Reviews. PMID 30171384 DOI: 10.1007/S10555-018-9760-Y |
0.726 |
|
| 2018 |
Prasad CP, Andersson T. Abstract B021: Inhibition of β-catenin impairs triple-negative breast cancer (TNBC) cell migration and invasion by modulating aerobic glycolysis components Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B021 |
0.725 |
|
| 2017 |
Prasad CP, Södergren K, Andersson T. Reduced production and uptake of lactate are essential for the ability of WNT5A signaling to inhibit breast cancer cell migration and invasion. Oncotarget. 8: 71471-71488. PMID 29069720 DOI: 10.18632/Oncotarget.17277 |
0.738 |
|
| 2017 |
Canesin G, Evans-Axelsson S, Hellsten R, Krzyzanowska A, Prasad CP, Bjartell A, Andersson T. Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model. Plos One. 12: e0184418. PMID 28886116 DOI: 10.1371/Journal.Pone.0184418 |
0.706 |
|
| 2017 |
Prgomet Z, Andersson T, Lindberg P. Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance. European Journal of Oral Sciences. 125: 237-246. PMID 28603941 DOI: 10.1111/Eos.12352 |
0.378 |
|
| 2017 |
Prasad CP, Södergren K, Andersson T. Reduced production and uptake of lactate are essential for the ability of WNT5A signaling to inhibit breast cancer cell migration and invasion. Oncotarget. PMID 28488573 DOI: 10.18632/oncotarget.17277 |
0.724 |
|
| 2016 |
Prasad CP, Chaurasiya SK, Guilmain W, Andersson T. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition. Journal of Experimental & Clinical Cancer Research : Cr. 35: 144. PMID 27623766 DOI: 10.1186/S13046-016-0421-0 |
0.72 |
|
| 2016 |
Mehdawi LM, Prasad CP, Ehrnström R, Andersson T, Sjölander A. Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells. Molecular Oncology. 10: 1415-1429. PMID 27522468 DOI: 10.1016/J.Molonc.2016.07.011 |
0.725 |
|
| 2016 |
Nanda VGY, Peng W, Hwu P, Davies MA, Ciliberto G, Fattore L, Malpicci D, Aurisicchio L, Ascierto PA, Croce CM, Mancini R, Spranger S, Gajewski TF, Wang Y, Ferrone S, ... ... Andersson T, et al. Melanoma and Immunotherapy Bridge 2015 : Naples, Italy. 1-5 December 2015 Journal of Translational Medicine. 14: 65-65. PMID 27461275 DOI: 10.1186/S12967-016-0791-2 |
0.604 |
|
| 2016 |
Linnskog R, Mohapatra P, Moradi F, Prasad CP, Andersson T. Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells: Dual interference of this loop more effectively impairs melanoma cell invasion. Oncotarget. PMID 27191257 DOI: 10.18632/Oncotarget.9332 |
0.679 |
|
| 2016 |
Moradi F, Berglund P, Linnskog R, Leandersson K, Andersson T, Prasad CP. Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration. Translational Research : the Journal of Laboratory and Clinical Medicine. 172: 45-60. PMID 26970271 DOI: 10.1016/J.Trsl.2016.02.007 |
0.716 |
|
| 2016 |
Canesin G, Evans-Axelsson S, Hellsten R, Sterner O, Krzyzanowska A, Andersson T, Bjartell A. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer. European Urology. 69: 400-4. PMID 26144873 DOI: 10.1016/J.Eururo.2015.06.016 |
0.425 |
|
| 2015 |
Prasad CP, Mohapatra P, Andersson T. Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer? Cancers. 7: 1900-24. PMID 26393652 DOI: 10.3390/Cancers7030868 |
0.672 |
|
| 2015 |
Prgomet Z, Axelsson L, Lindberg P, Andersson T. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 44: 776-84. PMID 25459554 DOI: 10.1111/Jop.12292 |
0.403 |
|
| 2015 |
Canesin G, Evans-Axelsson S, Hellsten R, Don-Doncow N, Andersson T, Bjartell A. Abstract 4476: Targeting Wnt5a and STAT3 pathways for the treatment of prostate cancer Cancer Research. 75: 4476-4476. DOI: 10.1158/1538-7445.Am2015-4476 |
0.464 |
|
| 2015 |
Andersson T, Axelsson L, Mohapatra P, Prasad C, Soerensen PG, Mau-Soerensen M, Lassen U, Molvadgaard T, Buhl U, Brünner N, Nielsen D. Abstract A116: Targeting the Wnt-5a signaling pathway as a novel anti-metastatic therapy Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-A116 |
0.722 |
|
| 2014 |
Linnskog R, Jönsson G, Axelsson L, Prasad CP, Andersson T. Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression. Molecular Oncology. 8: 1365-78. PMID 24954857 DOI: 10.1016/J.Molonc.2014.05.008 |
0.69 |
|
| 2014 |
Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, Andersson T, Leandersson K. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Molecular Cancer. 13: 88. PMID 24766647 DOI: 10.1186/1476-4598-13-88 |
0.423 |
|
| 2014 |
Sherwood V, Chaurasiya SK, Ekström EJ, Guilmain W, Liu Q, Koeck T, Brown K, Hansson K, Agnarsdóttir M, Bergqvist M, Jirström K, Ponten F, James P, Andersson T. WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism. Carcinogenesis. 35: 784-94. PMID 24293407 DOI: 10.1093/Carcin/Bgt390 |
0.47 |
|
| 2014 |
Soerensen PG, Andersson T, Buhl U, Moelvadgaard T, Jensen PB, Brunner N, Nielsen D. Phase I dose-escalating study to evaluate the safety, tolerability, and pharmacokinetic and pharmacodynamic profiles of Foxy-5 in patients with metastatic breast, colorectal, or prostate cancer. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.Tps1140 |
0.446 |
|
| 2013 |
Sand-Dejmek J, Ehrnström R, Berglund P, Andersson T, Ryden L. The prognostic significance of Wnt-5a expression in primary breast cancer is extended to premenopausal women. Plos One. 8: e70890. PMID 23990917 DOI: 10.1371/Journal.Pone.0070890 |
0.41 |
|
| 2013 |
Prasad CP, Chaurasiya SK, Axelsson L, Andersson T. WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells. Molecular Oncology. 7: 870-83. PMID 23727359 DOI: 10.1016/J.Molonc.2013.04.005 |
0.721 |
|
| 2013 |
Prgomet Z, Lindberg P, Andersson T. Wnt5a stimulates migration and invasion in OSCC Oral Oncology. 49. DOI: 10.1016/J.Oraloncology.2013.03.307 |
0.471 |
|
| 2012 |
Khaja AS, Egevad L, Helczynski L, Wiklund P, Andersson T, Bjartell A. Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer. Cancer Medicine. 1: 96-104. PMID 23342259 DOI: 10.1002/Cam4.5 |
0.352 |
|
| 2011 |
Syed Khaja AS, Helczynski L, Edsjö A, Ehrnström R, Lindgren A, Ulmert D, Andersson T, Bjartell A. Elevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcome. Plos One. 6: e26539. PMID 22039506 DOI: 10.1371/Journal.Pone.0026539 |
0.339 |
|
| 2011 |
Li B, Zhong L, Yang X, Andersson T, Huang M, Tang SJ. WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity. Plos One. 6: e22920. PMID 21857966 DOI: 10.1371/Journal.Pone.0022920 |
0.331 |
|
| 2011 |
Ekström EJ, Sherwood V, Andersson T. Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion. Plos One. 6: e18674. PMID 21494614 DOI: 10.1371/Journal.Pone.0018674 |
0.424 |
|
| 2011 |
Ford CE, Ekström EJ, Howlin J, Andersson T. The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer (Cell Cycle (2009), 8, (1838-1842)) Cell Cycle. 10: 1167. PMID 21430443 DOI: 10.4161/Cc.10.7.15488 |
0.417 |
|
| 2011 |
Magnusson C, Liu J, Ehrnström R, Manjer J, Jirström K, Andersson T, Sjölander A. Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients. International Journal of Cancer. 129: 9-22. PMID 20824707 DOI: 10.1002/Ijc.25648 |
0.422 |
|
| 2011 |
Sand-Dejmek J, Ehrnstrom R, Andersson T, Ryden L. P5-01-02: Wnt5a Is a Prognostic Biomarker in Estrogen Receptor-Positive Premenopausal Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P5-01-02 |
0.343 |
|
| 2010 |
Ford CE, Tuomela J, Hedditch EL, Axelsson L, Liu Q, Ward RL, Harkonen P, Andersson T. 43 Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5 Ejc Supplements. 8: 11-11. DOI: 10.1016/S1359-6349(10)70852-1 |
0.395 |
|
| 2009 |
Jenei V, Sherwood V, Howlin J, Linnskog R, Säfholm A, Axelsson L, Andersson T. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proceedings of the National Academy of Sciences of the United States of America. 106: 19473-8. PMID 19901340 DOI: 10.1073/Pnas.0909409106 |
0.511 |
|
| 2009 |
Hansen C, Howlin J, Tengholm A, Dyachok O, Vogel WF, Nairn AC, Greengard P, Andersson T. Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner. The Journal of Biological Chemistry. 284: 27533-43. PMID 19651774 DOI: 10.1074/Jbc.M109.048884 |
0.493 |
|
| 2009 |
Ford CE, Ekström EJ, Howlin J, Andersson T. The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERalpha negative breast cancer. Cell Cycle (Georgetown, Tex.). 8: 1838-42. PMID 19448401 DOI: 10.4161/Cc.8863 |
0.463 |
|
| 2009 |
Medrek C, Landberg G, Andersson T, Leandersson K. Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells. The Journal of Biological Chemistry. 284: 10968-79. PMID 19244247 DOI: 10.1074/Jbc.M804923200 |
0.433 |
|
| 2009 |
Ford CE, Ekström EJ, Andersson T. Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells Proceedings of the National Academy of Sciences of the United States of America. 106: 3919-3924. PMID 19237581 DOI: 10.1073/Pnas.0809516106 |
0.468 |
|
| 2008 |
Säfholm A, Tuomela J, Rosenkvist J, Dejmek J, Härkönen P, Andersson T. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 6556-63. PMID 18927296 DOI: 10.1158/1078-0432.Ccr-08-0711 |
0.478 |
|
| 2008 |
Howlin J, Rosenkvist J, Andersson T. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Breast Cancer Research. 10: 1-13. PMID 18435854 DOI: 10.1186/Bcr2087 |
0.467 |
|
| 2007 |
Ford CE, Lau SK, Zhu CQ, Andersson T, Tsao MS, Vogel WF. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma British Journal of Cancer. 96: 808-814. PMID 17299390 DOI: 10.1038/Sj.Bjc.6603614 |
0.321 |
|
| 2006 |
Hansen C, Greengard P, Nairn AC, Andersson T, Vogel WF. Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. Experimental Cell Research. 312: 4011-8. PMID 17027969 DOI: 10.1016/J.Yexcr.2006.09.003 |
0.493 |
|
| 2006 |
Jenei V, Deevi RK, Adams CA, Axelsson L, Hirst DG, Andersson T, Dib K. Nitric oxide produced in response to engagement of β2 integrins on human neutrophils activates the monomeric GTPases Rap1 and Rap2 and promotes adhesion Journal of Biological Chemistry. 281: 35008-35020. PMID 16963453 DOI: 10.1074/Jbc.M601335200 |
0.339 |
|
| 2006 |
Leandersson K, Riesbeck K, Andersson T. Wnt-5a mRNA translation is suppressed by the Elav-like protein HuR in human breast epithelial cells Nucleic Acids Research. 34: 3988-3999. PMID 16914445 DOI: 10.1093/Nar/Gkl571 |
0.366 |
|
| 2006 |
Dejmek J, Säfholm A, Nielsen CK, Andersson T, Leandersson K. Wnt-5a/Ca2+-induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1α signaling in human mammary epithelial cells Molecular and Cellular Biology. 26: 6024-6036. PMID 16880514 DOI: 10.1128/Mcb.02354-05 |
0.441 |
|
| 2006 |
Säfholm A, Leandersson K, Dejmek J, Nielsen CK, Villoutreix BO, Andersson T. A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells Journal of Biological Chemistry. 281: 2740-2749. PMID 16330545 DOI: 10.1074/Jbc.M508386200 |
0.474 |
|
| 2005 |
Dejmek J, Dejmek A, Säfholm A, Sjölander A, Andersson T. Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Research. 65: 9142-9146. PMID 16230369 DOI: 10.1158/0008-5472.Can-05-1710 |
0.428 |
|
| 2005 |
Jenei V, Andersson T, Jakus J, Dib K. E3B1, a human homologue of the mouse gene product Abi-1, sensitizes activation of Rap1 in response to epidermal growth factor. Experimental Cell Research. 310: 463-73. PMID 16182283 DOI: 10.1016/J.Yexcr.2005.08.010 |
0.33 |
|
| 2005 |
Kremenevskaja N, Wasielewski Rv, Rao A, Schofl C, Andersson T, Brabant G. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene. 24: 2144-2154. PMID 15735754 DOI: 10.1038/Sj.Onc.1208370 |
0.377 |
|
| 2005 |
Dejmek J, Leandersson K, Manjer J, Bjartell A, Emdin SO, Vogel WF, Landberg G, Andersson T. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 520-8. PMID 15701836 |
0.351 |
|
| 2005 |
Alvarado-Kristensson M, Andersson T. Protein phosphatase 2A regulates apoptosis in neutrophils by dephosphorylating both p38 MAPK and its substrate caspase 3. Journal of Biological Chemistry. 280: 6238-6244. PMID 15569672 DOI: 10.1074/Jbc.M409718200 |
0.32 |
|
| 2004 |
Grethe S, Ares MPS, Andersson T, Pörn-Ares MI. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-xL Experimental Cell Research. 298: 632-642. PMID 15265709 DOI: 10.1016/J.Yexcr.2004.05.007 |
0.325 |
|
| 2004 |
Alvarado-Kristensson M, Melander F, Leandersson K, Rönnstrand L, Wernstedt C, Andersson T. p38-MAPK Signals Survival by Phosphorylation of Caspase-8 and Caspase-3 in Human Neutrophils Journal of Experimental Medicine. 199: 449-458. PMID 14970175 DOI: 10.1084/Jem.20031771 |
0.307 |
|
| 2003 |
Chihab R, Pörn-Ares MI, Alvarado-Kristensson M, Andersson T. Sphingosine 1-phosphate antagonizes human neutrophil apoptosis via p38 mitogen-activated protein kinase. Cellular and Molecular Life Sciences. 60: 776-785. PMID 12785724 DOI: 10.1007/S00018-003-2357-8 |
0.33 |
|
| 2003 |
Pörn-Ares MI, Saido TC, Andersson T, Ares MP. Oxidized low-density lipoprotein induces calpain-dependent cell death and ubiquitination of caspase 3 in HMEC-1 endothelial cells. The Biochemical Journal. 374: 403-11. PMID 12775216 DOI: 10.1042/Bj20021955 |
0.329 |
|
| 2003 |
Dejmek J, Dib K, Jönsson M, Andersson T. Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion. International Journal of Cancer. 103: 344-351. PMID 12471617 DOI: 10.1002/Ijc.10752 |
0.449 |
|
| 2003 |
Melander F, Andersson T, Dib K. Fgr but not Syk tyrosine kinase is a target for beta2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils. Biochemical Journal. 370: 687-694. PMID 12435267 DOI: 10.1042/Bj20021201 |
0.305 |
|
| 2002 |
Dimitrijevic I, Axelsson L, Andersson T. The adhesion receptor CD-31 can be primed to rapidly adjust the neutrophil cytoskeleton. Biochemical and Biophysical Research Communications. 292: 1092-1097. PMID 11944928 DOI: 10.1006/Bbrc.2002.6773 |
0.308 |
|
| 2002 |
Alvarado-Kristensson M, Pörn-Ares MI, Grethe S, Smith D, Zheng L, Andersson T. p38 Mitogen-activated protein kinase and phosphatidylinositol 3-kinase activities have opposite effects on human neutrophil apoptosis. The Faseb Journal. 16: 129-131. PMID 11729103 DOI: 10.1096/Fj.01-0817Fje |
0.327 |
|
| 2001 |
Alvarado-Kristensson M, Poumlrn-Ares MI, Grethe S, Smith D, Zheng L, Andersson T. Fas-Induced Apoptosis of Human Neutrophils is Promoted by Phosphatidyl Inositol 3-Kinase but Suppressed by P38-MAPK Activity. Thescientificworldjournal. 1: 116. PMID 30147596 DOI: 10.1100/Tsw.2001.222 |
0.338 |
|
| 2001 |
Dib K, Melander F, Andersson T. Role of p190RhoGAP in beta 2 integrin regulation of RhoA in human neutrophils. Journal of Immunology. 166: 6311-6322. PMID 11342655 DOI: 10.4049/Jimmunol.166.10.6311 |
0.342 |
|
| 2000 |
Axelsson L, Hellberg C, Melander F, Smith D, Zheng L, Andersson T. Clustering of β2-Integrins on Human Neutrophils Activates Dual Signaling Pathways to PtdIns 3-Kinase Experimental Cell Research. 256: 257-263. PMID 10739672 DOI: 10.1006/Excr.2000.4816 |
0.318 |
|
| 1999 |
Hellberg C, Ydrenius L, Axelsson L, Andersson T. Disruption of β2-Integrin–Cytoskeleton Coupling Abolishes the Signaling Capacity of These Integrins on Granulocytes☆ Biochemical and Biophysical Research Communications. 265: 164-169. PMID 10548508 DOI: 10.1006/Bbrc.1999.1645 |
0.38 |
|
| 1997 |
Ydrenius L, Molony L, Ng-Sikorski J, Andersson T. Dual action of cAMP-dependent protein kinase on granulocyte movement. Biochemical and Biophysical Research Communications. 235: 445-450. PMID 9207173 DOI: 10.1006/Bbrc.1997.6822 |
0.353 |
|
| 1996 |
Zheng L, Sjolander A, Eckerdal J, Andersson T. Antibody-induced engagement of beta 2 integrins on adherent human neutrophils triggers activation of p21ras through tyrosine phosphorylation of the protooncogene product Vav. Proceedings of the National Academy of Sciences of the United States of America. 93: 8431-8436. PMID 8710888 DOI: 10.1073/Pnas.93.16.8431 |
0.35 |
|
| 1995 |
Hellberg C, Eierman D, Sjölander A, Andersson T. The Ca2+ Signaling Capacity of the β2-Integrin on HL60-Granulocytic Cells Is Abrogated Following Phosphorylation of Its CD18-Chain: Relation to Impaired Protein Tyrosine Phosphorylation Experimental Cell Research. 217: 140-148. PMID 7532590 DOI: 10.1006/Excr.1995.1073 |
0.351 |
|
| 1991 |
Bengtsson T, Dahlgren C, Stendahl O, Andersson T. Actin assembly and regulation of neutrophil function: effects of cytochalasin B and tetracaine on chemotactic peptide-induced O2- production and degranulation. Journal of Leukocyte Biology. 49: 236-244. PMID 1847714 DOI: 10.1002/Jlb.49.3.236 |
0.323 |
|
| 1990 |
Bengtsson T, Sarndahl E, Stendahl O, Andersson T. Involvement of GTP-binding proteins in actin polymerization in human neutrophils. Proceedings of the National Academy of Sciences of the United States of America. 87: 2921-2925. PMID 2109319 DOI: 10.1073/Pnas.87.8.2921 |
0.302 |
|
| 1988 |
Andersson T, Fällman M, Lew DP, Stendahl O. Does protein kinase C control receptor-mediated phagocytosis in human neutrophils? Febs Letters. 239: 371-375. PMID 2846363 DOI: 10.1016/0014-5793(88)80954-2 |
0.344 |
|
| 1986 |
Stendahl O, Andersson T, Dahlgren C, Magnusson K. Defective chemiluminescence response in differentiated HL60 cells due to impaired degranulation Biochimica Et Biophysica Acta. 881: 430-436. PMID 3008851 DOI: 10.1016/0304-4165(86)90036-X |
0.343 |
|
| Show low-probability matches. |